Journal of the American Society of Nephrology (JASN) podkast

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

10.10.2023

Journal of the American Society of Nephrology (JASN)

0:00

25:37

In this podcast, EIC Josie Briggs talks with Giuseppe Remuzzi about the NEPHSTROM Trial & the next steps in translational work to test the possibility that mesenchymal stem cells can be used as a therapeutic agent to promote repair of kidney damage.

Więcej odcinków z kanału "Journal of the American Society of Nephrology (JASN)"

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury
16.05.2024
1:09:15
The effect of pantoprazole on eGFR slope, antiviral medications for Herpes Zoster, & link between pediatric AKI in Uzbekistan and cough syrups are covered in this episode of ASN Kidney Translation: An ASN Journals' Podcast.
Tubular Effect of Proteinuria
1.05.2024
10:57
Andrew Hall discusses results of his study, "Spatiotemporal Landscape of Kidney Tubular Responses to Glomerular Proteinuria," with JASN Deputy Editor David H. Ellison.
Nie przegap odcinka z kanału “Journal of the American Society of Nephrology (JASN)”! Subskrybuj bezpłatnie w aplikacji GetPodcast.
Set7 Regulates Glomerular Injury
25.04.2024
25:38
Assam El-Osta discusses the findings from his study, "Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells," with JASN Deputy Editor David H. Ellison.
Daprodustat and Heart Failure in CKD
10.04.2024
19:18
Jonathan W. Cunningham and Ajay K. Singh discuss the results of their study, "Daprodustat and Heart Failure in CKD," with JASN Deputy Editor David H. Ellison.
Changes in ESKD Incidence
13.03.2024
10:41
Susan R. Mendley and Chyng-Wen Fwu discuss the findings of their study, "Age- and Race-Specific Changes in ESKD Incidence over Four Decades," with JASN Editor-in-Chief Rajnish Mehrotra.
Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN
12.01.2024
25:36
In this podcast, outgoing Editor-in-Chief Josie Briggs talks with incoming Editor-in-Chief Raj Mehrotra about his vision for the next chapter of JASN.
SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade
21.11.2023
21:23
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.
Kidney Transplant Registry Data: Advice for Users
24.10.2023
18:43
In this podcast, EIC Josie Briggs talks with Associate Editor John Gill about the valuable data resources for research on kidney transplantation. Drs. Gill and Briggs provide some advice for users of these important resources.
Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease
10.10.2023
25:37
In this podcast, EIC Josie Briggs talks with Giuseppe Remuzzi about the NEPHSTROM Trial & the next steps in translational work to test the possibility that mesenchymal stem cells can be used as a therapeutic agent to promote repair of kidney damage.
Historical Redlining and the Incidence of Kidney Failure in US Cities
24.08.2023
15:39
In the podcast, EIC Josie Briggs discusses a paper entitled "Structural Racism, Historical Redlining, and Incidence of Kidney Failure in US Cities" with co-authors Kevin Nguyen and Deidre Crews.

Więcej odcinków

Odkrywaj najlepsze podcasty dzięki bezpłatnej aplikacji GetPodcast.

Subskrybuj ulubione podcasty, słuchaj odcinków offline i sprawdzaj najlepsze polecane podcasty.

Polityka prywatności
Informacja prawna
Polska

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

Journal of the American Society of Nephrology (JASN)

Więcej odcinków z kanału "Journal of the American Society of Nephrology (JASN)"

ASN Kidney Translation Series: PPI, Antivirals, and Cough Syrups: Nephrotoxins and Kidney Injury

Tubular Effect of Proteinuria

Set7 Regulates Glomerular Injury

Daprodustat and Heart Failure in CKD

Changes in ESKD Incidence

Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

Kidney Transplant Registry Data: Advice for Users

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

Historical Redlining and the Incidence of Kidney Failure in US Cities